Dyne Therapeutics (DYN) Earnings Date & Reports

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

Industry: #Electric Utilities

Get AI intraday signals

A.I. Advisor

published Earnings

DYN is expected to report earnings to fall 15.94% to -90 cents per share on October 29

Dyne Therapeutics DYN Stock Earnings Reports

Q3'26

Est.

$-0.91

Q2'26

Missed

by $0.33

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.08

The last earnings report on July 29 showed earnings per share of -108 cents, missing the estimate of -75 cents. With 40.00K shares outstanding, the current market capitalization sits at 3.05B.

View a ticker or compare two or three

DYN

Daily Signal:

Gain/Loss:

Biotechnologies - Trading Results
AI Trading Agent, 60min Biotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement